Gene: ALKBH2
Official Full Name: alkB homolog 2, alpha-ketoglutarate dependent dioxygenaseprovided by HGNC
Gene Summary: The Escherichia coli AlkB protein protects against the cytotoxicity of methylating agents by repair of the specific DNA lesions generated in single-stranded DNA. ALKBH2 and ALKBH3 (MIM 610603) are E. coli AlkB homologs that catalyze the removal of 1-methyladenine and 3-methylcytosine (Duncan et al., 2002 [PubMed 12486230]).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29039 | ALKBH2 Knockout cell line (HeLa) | Human | ALKBH2 | 1:3~1:6 | Negative | Online Inquiry |
KO29040 | ALKBH2 Knockout cell line (HCT 116) | Human | ALKBH2 | 1:2~1:4 | Negative | Online Inquiry |
KO29041 | ALKBH2 Knockout cell line (HEK293) | Human | ALKBH2 | 1:3~1:6 | Negative | Online Inquiry |
KO29042 | ALKBH2 Knockout cell line (A549) | Human | ALKBH2 | 1:3~1:4 | Negative | Online Inquiry |
ALKBH2 Gene Knockout Cell Lines are genetically engineered cell lines that have been specifically designed to lack the functional ALKBH2 gene, which encodes for a dioxygenase involved in RNA demethylation processes. These knockout cell lines serve as crucial tools for investigating the role of ALKBH2 in various biological processes, especially in relation to gene expression regulation, stress responses, and RNA metabolism.
The main function of ALKBH2 is to remove methyl groups from nucleic acids, a process that can influence RNA stability and translation efficiency. By utilizing these knockout cell lines, researchers can study the downstream effects of ALKBH2 deficiency, providing insights into the mechanisms of epitranscriptomics— the regulatory layer of gene expression modulated by RNA modifications. The absence of ALKBH2 allows for a clearer understanding of how RNA methylation impacts cellular processes, offering valuable information that can elucidate pathways involved in diseases such as cancer and neurodegeneration.
In research and clinical settings, ALKBH2 Gene Knockout Cell Lines are particularly significant for investigating the pathophysiological implications of altered RNA methylation patterns. They enable scientists to conduct functional assays, drug screening, and therapeutic development aimed at diseases tied to aberrant RNA modifications. These cell lines provide a standardized model to observe the effects of pharmacological interventions or genetic manipulations on cellular behavior related to ALKBH2.
One distinct advantage of using ALKBH2 Gene Knockout Cell Lines over other alternatives is their precise genetic modification and characterization, which warrant reproducibility and reliability in experimental results. Unlike transient knockdown methods involving siRNA or shRNA, these stable knockout cell lines ensure sustained and consistent loss of function, making them a superior choice for long-term studies.
For researchers and clinicians, ALKBH2 Gene Knockout Cell Lines represent an invaluable asset in the quest to understand and manipulate gene expression mechanisms. They enable groundbreaking discoveries that can lead to novel therapeutic strategies or insights into disease mechanisms.
Our company specializes in providing high-quality genetic tools for the scientific community, backed by years of expertise in cell line development and genomic engineering. With our commitment to innovation and precision, we deliver products tailored for advancing research and clinical applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.